- 2025-04-12 17:33ALK-IN-21 2901889-01-6
- 2025-04-12 17:33Antiviral agent 23 35940-03-5
- 2025-04-12 17:33ADC Control Human IgG1-SN-38
- 2025-04-12 17:33PD173955 260415-63-2
- 2025-04-12 17:33ALKBH1-IN-3
- 2025-04-12 17:33Briobacept (BR 3FC) 869881-54-9
- 2025-04-12 17:3313(S)-HPODE 33964-75-9
- 2025-04-12 17:33(Z)-Orantinib ((Z)-SU6668) 210644-62-5
- 2025-04-12 17:3317-AEP-GA 75747-23-8
- 2025-04-12 17:33PT2399 1672662-14-4
- 2025-04-12 17:33GANT58 (NSC 75503) 64048-12-0
- 2025-04-12 17:33Cabenoside D 88901-40-0
- 2025-04-12 17:33FAK inhibitor 7 2890814-94-3
- 2025-04-12 17:33Tricin-d6
- 2025-04-12 17:33(2R,4R)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate 114676-69-6
- 2025-04-12 17:33(-)-trans-Myrtanol 53369-17-8
- 2025-04-12 17:33D-65476 249762-74-1
- 2025-04-12 17:33LCMV GP (61-80) 232598-19-5
- 2025-04-12 17:33MK-8457 1312518-84-5
- 2025-04-12 17:33Anti-SEZ6 Antibody (SC17)
